Ultrasound Elastography of Breast Lesions (BE1)

S

Supersonic Imagine

Status

Completed

Conditions

Breast Neoplasms

Study type

Observational

Funder types

Industry

Identifiers

NCT00716482
A00152-53

Details and patient eligibility

About

Our hypothesis is that the addition of ShearWave Elastography (SWE) to a conventional breast ultrasound examination provides useful information for the radiologist when imaging lesions in the breast, as compared to conventional grayscale ultrasound alone.

Enrollment

1,681 patients

Sex

Female

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients who have been referred to a breast ultrasound because of a positive physical palpation and/or positive mammograms and/or positive ultrasound and/or positive MRI.
  • female
  • age 21 or older
  • provide informed consent

Exclusion criteria

  • Women who are unwilling or unable to provide informed consent
  • Women with breast implants
  • Women with superficial lesions or lesions on skin (with the most superficial surface of the lesion within 5 mm of the skin surface)
  • Women who are pregnant or breastfeeding
  • Women who are undergoing chemotherapy or radiotherapy for any cancer
  • Women with previous breast conserving surgery on the breast of interest Note: Previous excision of a benign lesion 4 cm or more away from the suspected lesion does not constitute an exclusion criterion.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems